NO971238D0 - Fluoralkyl- og fluoralkoksy-substiturete heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse derav - Google Patents

Fluoralkyl- og fluoralkoksy-substiturete heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse derav

Info

Publication number
NO971238D0
NO971238D0 NO971238A NO971238A NO971238D0 NO 971238 D0 NO971238 D0 NO 971238D0 NO 971238 A NO971238 A NO 971238A NO 971238 A NO971238 A NO 971238A NO 971238 D0 NO971238 D0 NO 971238D0
Authority
NO
Norway
Prior art keywords
fluoroalkoxy
fluoroalkyl
preparation
substituted heterocyclic
bradykinin antagonists
Prior art date
Application number
NO971238A
Other languages
English (en)
Other versions
NO971238L (no
Inventor
Adalbert Wagner
Holger Heitsch
Gerhard Noelken
Klaus Wirth
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO971238D0 publication Critical patent/NO971238D0/no
Publication of NO971238L publication Critical patent/NO971238L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/10Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D257/12Six-membered rings having four nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO971238A 1996-03-19 1997-03-18 Fluoralkyl- og fluoralkoksy-substituerte heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse derav NO971238L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19610784A DE19610784A1 (de) 1996-03-19 1996-03-19 Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number Publication Date
NO971238D0 true NO971238D0 (no) 1997-03-18
NO971238L NO971238L (no) 1997-09-22

Family

ID=7788755

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971238A NO971238L (no) 1996-03-19 1997-03-18 Fluoralkyl- og fluoralkoksy-substituerte heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse derav

Country Status (24)

Country Link
US (1) US5859025A (no)
EP (1) EP0796848B1 (no)
JP (1) JP4199315B2 (no)
KR (1) KR970065522A (no)
AR (1) AR006261A1 (no)
AT (1) ATE242215T1 (no)
AU (1) AU1628397A (no)
BR (1) BR9701332A (no)
CA (1) CA2199925A1 (no)
CZ (1) CZ81097A3 (no)
DE (2) DE19610784A1 (no)
DK (1) DK0796848T3 (no)
ES (1) ES2196207T3 (no)
HR (1) HRP970155A2 (no)
HU (1) HUP9700595A1 (no)
ID (1) ID16274A (no)
IL (1) IL120477A0 (no)
NO (1) NO971238L (no)
PL (1) PL318924A1 (no)
PT (1) PT796848E (no)
SI (1) SI0796848T1 (no)
SK (1) SK34897A3 (no)
TR (1) TR199700206A2 (no)
ZA (1) ZA972328B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
ATE257479T1 (de) * 1999-12-10 2004-01-15 Pfizer 5-ring heteroarylsubstituierte 1,4- dihydropyridine als bradykinin antagonisten
WO2003087090A2 (en) * 2002-04-10 2003-10-23 Ortho-Mcneil Pharmaceutical,Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
US7256207B2 (en) * 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
WO2006094034A1 (en) 2005-03-01 2006-09-08 Wyeth Cinnoline compounds and their use as liver x receptor modilators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AR085073A1 (es) * 2012-01-11 2013-09-11 Richmond Sa Com Ind Y Financiera Lab Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden
CA3082948A1 (en) 2017-11-24 2019-05-31 Pharvaris Netherlands B.V. Novel bradykinin b2 receptor antagonists
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
KR20240039185A (ko) 2021-08-05 2024-03-26 파르바리스 게엠베하 브래디키닌 b2-수용체 길항제의 경구 투여용 지질 기반 조성물
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
WO2023180575A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996005202A1 (fr) * 1994-08-17 1996-02-22 Nippon Hypox Laboratories Inc. Derive de l'imidazoquinoleine
KR970707098A (ko) * 1994-10-27 1997-12-01 후지야마 아키라 브라디키닌 길항제로서 피리도피리미돈, 퀴놀린 및 융합된 N-헤테로사이클(Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists)

Also Published As

Publication number Publication date
HRP970155A2 (en) 1998-04-30
US5859025A (en) 1999-01-12
EP0796848B1 (de) 2003-06-04
ZA972328B (en) 1997-09-19
IL120477A0 (en) 1997-07-13
TR199700206A2 (xx) 1997-10-21
AR006261A1 (es) 1999-08-11
JP4199315B2 (ja) 2008-12-17
AU1628397A (en) 1997-09-25
ES2196207T3 (es) 2003-12-16
BR9701332A (pt) 1998-08-18
SI0796848T1 (en) 2003-12-31
PT796848E (pt) 2003-08-29
DK0796848T3 (da) 2003-09-22
JPH107656A (ja) 1998-01-13
KR970065522A (ko) 1997-10-13
ATE242215T1 (de) 2003-06-15
NO971238L (no) 1997-09-22
MX9702028A (es) 1997-09-30
CZ81097A3 (en) 1997-10-15
DE59710191D1 (de) 2003-07-10
DE19610784A1 (de) 1997-09-25
ID16274A (id) 1997-09-18
EP0796848A1 (de) 1997-09-24
PL318924A1 (en) 1997-09-29
HUP9700595A1 (hu) 2000-08-28
CA2199925A1 (en) 1997-09-19
SK34897A3 (en) 1998-01-14
HU9700595D0 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
NO971238D0 (no) Fluoralkyl- og fluoralkoksy-substiturete heterocykliske bradykinin-antagonister og fremgangsmåte for fremstilling og anvendelse derav
PT929528E (pt) Lactamas e imidas heterociclicas de aralquilo e de aralquilideno
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
NO972125L (no) Hemorroideblandinger og fremgangsmåte for anvendelse
BR9703890A (pt) Piridinas heterocíclicas fundidas
NO990122L (no) Nedihullverkt°y og fremgangsmÕte
DK0954588T3 (da) OB fusionsprotein-sammensætninger og fremgangsmåder
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
NO20001015D0 (no) Cellulosestruktur med forskjellig densitet og fremgangsmõte for fremstilling derav
NO992838D0 (no) Benzotiofenkarboksamid-derivater og PGD2 antagonister omfattende disse
NO973365D0 (no) Fremgangsmåte for baking og tilhörende anordning
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
DE69708879D1 (de) Z-achsenzwischenverbindungsverfahren und schaltung
FI963655A (fi) Polypeptidien parannettu eritys
NO960309D0 (no) Agonister og antagonister for humaninterleukin-10
NO20003070L (no) Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav
DK21995A (da) Forbinding og fremgangsmade til fremstilling af forbinding
NO972477D0 (no) Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse
NO980718D0 (no) Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer
NO20006059L (no) Sammensatt element og fremgangsmåte for anvendelse
DE19782204T1 (de) Verlängerungseinrichtung und Verfahren
BR9508380A (pt) Derivados de azalonas heterocíclicos anti-helicobacter
NO991254D0 (no) FremgangsmÕter og mellomprodukter for fremstilling av substituerte kromanolderivater
NO20001718D0 (no) Benzen-fusjonerte heterocykliske derivater og anvendelse derav
PL330257A1 (en) Novel heterocyclic derivatives of benzocycloalkene, method of obtaining them and therapeutic agent